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ABSTRACT HIV-1 nucleocapsid protein, NCp7, contains two highly conserved CCHC zinc ﬁngers. Binding of Zn21 drives
NCp7 from an unfolded to a highly folded structure that is critical for its functions. Using the intrinsic ﬂuorescence of Trp37, we
investigated, by the stopped-ﬂow technique, the folding of NCp7 distal ﬁnger through the pH dependence of its Zn21 association
and dissociation kinetics. Zn21 binding was found to involve four different paths associated with the four deprotonated states of
the ﬁnger. Each binding path involves the rapid formation of an intermediate complex that is subsequently rearranged and
stabilized in a rate-limiting step. The equilibrium and kinetic rate constants of the full Zn21-binding process have been de-
termined. At neutral pH, the preferential pathway for the Zn21-driven folding implies Zn21 binding to the deprotonated Cys36 and
His44 residues, in the bidentate state of the ﬁnger. The resulting intermediate is then converted with a rate constant of 500 s1
into a more suitably folded form, probably through a rearrangement of the peptide backbone around Zn21 to optimize the bind-
ing geometry. This form then rapidly leads to the ﬁnal native complex, through deprotonation of Cys39 and Cys49 residues and
intramolecular substitution of coordinated water molecules. Zn21 dissociation is also characterized by a multistep process and
occurs fastest via the deprotonated Zn21-bound bidentate state with a rate constant of 3 s1. Due to their critical role in folding,
the intermediates identiﬁed for the ﬁrst time in this study may constitute potential targets for HIV therapy.
INTRODUCTION
A large number of protein domains folds stably by binding a
metal ion (1). This is notably the case of the zinc ﬁngers since
their proper folding depends solely on the binding of Zn21
and can be studied independently of the bulk protein (1,2).
This structural role of Zn21 is illustrated by the HIV-1 nu-
cleocapsid protein, NCp7, which is a small basic protein with
two highly conserved CCHC zinc ﬁngers (1,3,4). The two
ﬁngers of NCp7 bind Zn21 strongly and this results in a con-
formational change from an unfolded to a highly folded
structure (5–9). Besides its histone-like activity (10,11), NCp7
plays a role in several key steps of the viral life cycle through
interactions with nucleic acids and viral proteins (4,12–15).
The Zn21-promoted folding of the ﬁngers is critical for most
NCp7 functions. Indeed, Zn21 ejecting agents that disrupt
the zinc ﬁngers (16,17) and amino-acid mutations (18–21)
that prevent or affect Zn21 binding, lead to noninfectious vi-
ruses. Disrupted or mutated NCp7 sequences fail to recog-
nize and package the genomic RNA into new virus particles.
Zn21 coordination is also required for NCp7 nucleic acid
chaperone activity, which assists the rearrangement of nu-
cleic acid molecules into their most stable conformation
notably during reverse transcription (15,22–27). The critical
role of NCp7 zinc ﬁngers in HIV-1 replication, together with
their highly conserved sequence, makes these domains attrac-
tive targets for the development of antiviral drugs (16,28,29).
Due to their Zn21-triggered folding, the zinc ﬁngers of
NCp7 are suitable tools to investigate protein folding. In a
previous study, we have investigated at equilibrium the Zn21
coordination to the (35–50)NCp7 peptide (Fig. 1), repre-
senting the C-terminal ﬁnger of NCp7 (9). The four Zn21-
coordinating residues (Cys36, Cys39, His44, Cys49) were found
to deprotonate nearly sequentially, suggesting a stepwise bind-
ing of Zn21 to these residues. Since the complexity of the
binding mechanism increases with the number of Zn21-
coordinating residues, we investigated ﬁrst the binding ki-
netics of two selected point mutated peptides where one of
the coordinating residues was mutated into a noncoordinat-
ing one (30). The kinetics of Zn21 binding and dissociation
to these point-mutated peptides indicate a multistep process
involving three Zn21 binding paths due to three depro-
tonated states of the coordinating motif (30). In both point-
mutated peptides, the Zn21 binding process is initiated by the
deprotonation of Cys36 residue while the ﬁnal complex is
reached by subsequent stepwise ligand deprotonation and
intramolecular substitution of coordinated water molecules.
Moreover, the binding rate constants of the various deproton-
ated states of the point-mutated peptides suggested that con-
formational constraints are required to achieve proper metal
coordination during folding. The mechanistic analysis of the
point-mutated peptides thus provided a good starting point
for the interpretation of the more complex binding behavior
of the native peptide.
In this work, we investigate the dynamics of Zn21 associ-
ation and dissociation to (35–50)NCp7 at different pH values
by the stopped-ﬂow technique under anaerobic conditions.
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The binding of Zn21 is monitored through the Trp37 intrinsic
ﬂuorescence, which constitutes a sensitive reporter for the
folding of NCp7 distal ﬁnger (9,30,31). Binding of Zn21 to
(35–50)NCp7 is characterized by two kinetic phases involving
the rapid formation of intermediates that are subsequently
rearranged in a rate-limiting step to lead to the constrained
ﬁnal complex. Our data allow us to develop a general re-
action scheme and to propose the preferred pathway for
Zn21 binding and associated folding at neutral pH.
MATERIALS AND METHODS
Materials
The (35–50)NCp7 peptide was synthesized in its apo-form by solid-phase
synthesis and puriﬁed by HPLC as previously described (32). Buffers were
chosen to cover the following pH ranges: n,n9-diethyl-n,n9-bis-(sulfopropyl)-
ethylenediamine (DESPEN) for pH 4.7–5.6, 2-(n-morpholino)-ethanesulfonic
acid (MES) for pH 5.6–6.8, 4-(2-hydroxyethyl)-piperazine-1-ethanesulfonic
acid (HEPES) for pH 6.8–8.5. To minimize interactions between electrolyte
anions and Zn21, NaClO4 was used to ﬁx the ionic strength at 0.15 M. The
Zn21 solutions were prepared with Zn(ClO4)2 and degassed before use. Ex-
perimental conditions were such that hydrolysis of Zn21 was avoided. The
peptides were dissolved in degassed buffer and poured immediately into
quartz cells (Hellma, Muellheim/Baden, Germany) speciﬁcally conceived to
maintain an inert argon atmosphere. The SH content of the free peptides
during the experiments was reduced by less than 15% as checked by titration
with 5,59-dithiobis(2-nitrobenzoic acid) (33).
Absorption and ﬂuorescence spectroscopy
Peptide concentration was determined on a HP8450A diode array (Hewlett-
Packard, Palo Alto, CA) absorption spectrophotometer, using a molar ex-
tinction coefﬁcient of 5700 M1 cm1 at 280 nm. Fluorescence spectra were
recorded at 206 0.5C with a thermostated Fluorolog 212 (Spex CertiPrep,
Metuchen, NJ) spectroﬂuorimeter. Excitation was at 280 nm. An inert argon
atmosphere was maintained in the sample cell all over the measurements.
Stopped-ﬂow kinetics
Kinetic measurements were performed at 206 0.5C on a DX 17MV stopped-
ﬂow (Applied Photophysics, Leatherhead, Surrey, United Kingdom) instru-
ment using ﬂuorescence detection as previously described (30). To preserve
anaerobic conditions, the stopped-ﬂow apparatus was in a glove-box with an
atmosphere of puriﬁed nitrogen (quality 4.6). All reported concentrations of
reactants correspond to those after mixing. In association experiments,
pseudo-ﬁrst-order conditions were ensured by applying Zn21concentrations
at least 10-fold larger than the peptide concentration. Typically, 4–7 indi-
vidual time courses were recorded under the same experimental conditions,
for each evaluation. At pH 5.6 and 6.8, measurements were carried out in
two different buffers to check the absence of buffer effects. Dilution ex-
periments were performed to follow the dissociation reaction directly. A
solution of Zn21-peptide complex in a 1 ml syringe was mixed with buffer
in a 2.5 ml syringe, providing a 3.5 dilution factor. In these conditions,
signiﬁcant Zn21 dissociation was observed only at pH # 6.0.
pH indicator experiment
Kinetic experiments at pH 6.8 using Bromothymol Blue as a pH indicator
(pKa¼ 7) were performed with the above described stopped-ﬂow instrument
using absorption detection (model No. R928 photomultiplier, Hamamatsu,
Hamamatsu City, Japan). The light source was a 250 W Tungsten lamp
(Osram, Munich, Germany). Kinetics was monitored at 450 nm (absorption
maximum of the acidic form of Bromothymol Blue), 494 nm (isosbestic point),
and 615 nm (absorption maximum of the basic form of Bromothymol Blue).
Kinetic data analysis
The apparent rate constants kobs and the amplitudes were determined from
the kinetic data by extrapolating the kinetic phase to the true time zero by
taking in account the experimentally determined dead time of 1.6 ms (34).
All time-resolved kinetic phases could be analyzed with a monoexponential
function. All ﬁttings were carried out with the Origin (Microcal, Northampton,
MA) software based on the nonlinear least-square method applying the
Levenberg-Marquardt algorithm. All equilibrium constants are expressed as
association constants.
RESULTS
Zn21 binding kinetics at a single pH value
Since the Zn21 binding information is fully encoded by the
zinc ﬁngers (8), the (35–50)NCp7 peptide (Fig. 1) corre-
sponding to the distal ﬁnger of NCp7 has been selected as a
relevant model (9). The dynamics of Zn21 binding to (35–50)
NCp7 is investigated under pseudo-ﬁrst-order conditions by
the ﬂuorescence stopped-ﬂow technique in anaerobic condi-
tions, as previously described (30). In Fig. 2 a, the measured
time course upon rapid mixing of 1.5 mM (35–50)NCp7 with
350 mM Zn(ClO4)2 in 50 mM MES pH 6.8 is shown as a
representative example. The time-resolved kinetic phase can
be ﬁtted to a monoexponential function providing one ob-
served rate constant kobs. Experiments at different Zn
21 con-
centrations indicate a saturation behavior of kobs (Fig. 2 b)
and not the linear Zn21 concentration-dependence associated
to a one-step reaction that was previously observed for the
point-mutated peptides (30). This saturation behavior is con-
sistent with a two-step reaction scheme, where a rate-limiting
interconversion step is coupled to a much faster, preceding
binding step, considered as a preequilibrium:
L1Zn21E*
K

M
LZn
21
E*
kf
kb
LZn
21
: (1)
Consequently, a comparatively stable intermediate complex,
LZn21*, is postulated. By ﬁtting the Zn21concentration de-
pendence of kobs to (35)
FIGURE 1 Amino-acid sequence of (35–50)NCp7. Trp37 is boxed.
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kobs ¼ kfK

M½Zn21 
11KM½Zn21 
1 kb; (2)
a value of (9 6 1) 3 103 M1 is obtained for KM, the
association equilibrium constant of the LZn21* complex, and
a value of 500620 s1 is obtained for the sum of the forward
(kf) and backward (kb) interconversion rate constants. The
value of kb, given by the intercept, is very low (,0.1 s
1) and
cannot be determined from the experimental data. Thus, the
value of 500 s1 corresponds essentially to kf.
According to the two-step reaction scheme, a fast un-
resolvable process attributed to the formation of LZn21* is
expected. In line with this expectation, the ﬂuorescence in-
tensity at the onset of the time-resolvable process is always
markedly higher than the ﬂuorescence intensity of the apo-
peptide (Fig. 2 a). The amplitudes of the nonresolvable and
the resolvable processes are denoted A1 and A2, respectively
(Fig. 2, a and c), and their sum represents the total amplitude
change Atot. In our conditions, Atot is nearly independent of the
Zn21 concentration (Fig. 2 c), indicating that the ﬁnal Zn21-
ligand complex is formed completely even at the lowest Zn21
concentration. On the other hand, A1 clearly increases with the
Zn21 concentration and reaches a plateau value, A1Max, corre-
sponding to the ﬂuorescence of the LZn21* complex. The
Zn21 concentration dependence of A1 can be used to deter-
mine the equilibrium association constant, KM, of LZn
21*,
according to
A1 ¼ K

M½Zn21 A1Max
11KM½Zn21 
: (3)
The obtained KM value of (361)3 10
3 M1 is in agreement
with the one obtained from the Zn21 concentration de-
pendence of kobs (Fig. 2 b), demonstrating the consistency
between kinetic and thermodynamic parameters.
pH dependence of the kinetic parameters
Since deprotonation reactions are involved in the Zn21
binding reaction (9), the kinetic experiments were carried out
between pH 5.2 and pH 8.5. The pH dependence of the for-
ward interconversion rate-constant kf is displayed in Fig. 3 a.
Surprisingly, the highest kf value (850 s1) is observed at
the lowest investigated pH; then kf decreases with increasing
pH. According to Eq. 2, the KM values, determined from
the Zn21 concentration dependences of kobs, are also pH-
dependent (Fig. 3 b). The resulting slope is 1.356 0.02 indi-
cating that Zn21-binding requires the deprotonation of one to
FIGURE 2 Zn21 binding kinetics to (35–50)NCp7 at pH 6.8. The peptide
was 1.5 mM in 50 mM HEPES/NaOH pH 6.8 at a total ionic strength of
0.15 M. (a) Representative kinetic experiment. Rapid mixing of the peptide
with 0.35 mM Zn(ClO4)2 is performed at 20C. The solid line is the best ﬁt
to a monoexponential function with kobs ¼ 330 s1. A dead time of 1.6 ms
is taken into account (see Materials and Methods). The concentrations are
those after mixing. The ﬂuorescence of the apopeptide is indicated. A1 and
A2 are the amplitudes of the non-time-resolved and time-resolved processes,
respectively. (b) Dependence of kobs on the total Zn
21 concentration. The
solid line is the best ﬁt to the experimental data according to Eq. 2 with
kf ¼ 500 s1 and KM ¼ 9000M1: (c) Dependence of the relative
ﬂuorescence amplitudes on the total Zn21 concentration: A1, d, A2, s,
and total amplitude Atot, n. The dashed line indicates the ﬂuorescence of the
ﬁnal complex. A1Max is the non-time-resolved amplitude at high
[Zn(ClO4)2]. The solid line is the best ﬁt to the A1 values using Eq. 3 with
KM ¼ ð36 1Þ3 103M1 and A1Max ¼ 0.74 6 0.05.
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two Zn21 coordinating residues before the rate-limiting step.
Since the peptide contains four Zn21 coordinating residues,
additional deprotonation steps are expected to occur subse-
quently to the rate-limiting step.
Due to its low value, the backward interconversion rate
constant kb can be determined by dilution-induced dissoci-
ation experiments (34) only at low pH from
kobs ¼ kf
11
3:5
K

M½Zn21 Tot
1 kb; (4)
where [Zn21]Tot is the total, i.e., free and bound, concen-
tration of Zn21 in the syringe containing the Zn21 bound
peptide. We obtained 0.9 s1 and 0.08 s1 for kb at pH 5.6
and 6.0, respectively, indicating that the dissociation rate is
also pH-dependent (Fig. 3 c). Alternatively, under the con-
dition kf/kb 1, the kb value can be calculated from the overall
Zn21 binding equilibrium constant Kapp (9) according to
kb ¼ K

Mkf
Kapp
: (5)
The acceptable agreement between the calculated and mea-
sured values of kb at pH 5.6 and 6.0 (Fig. 3 c) gives conﬁ-
dence to the calculated values of kb and their pH dependence.
The linear part of the curve in Fig. 3 c is characterized by a
slope of 2.2 6 0.1, indicating that protonation of two Zn21
coordinating groups takes place before the rate-limiting dis-
sociation step kb. Based on the principle of microscopic re-
versibility, two corresponding fast deprotonation steps have
to occur also in the opposite direction, namely subsequent to
the rate-limiting binding step, kf. Because these steps are
much faster than the rate-limiting binding step, they cannot
affect the kf value. Conversely, it should be possible to detect
this rate-limiting step through the pH change originating
from the subsequent deprotonation. To this purpose, a stopped-
ﬂow experiment with absorption detection was performed by
mixing (35–50)NCp7 with Zn(ClO4)2 in 5 mM MES pH 6.8
in the presence of Bromothymol Blue as a suitable pH in-
dicator. In line with our hypothesis, a time-resolvable process
was observed (Fig. 4) with a kobs of 235 s
1, very close to
that found for Zn21 binding. This result indicates that cation
binding and the pH change revealed by the indicator are
controlled by the same rate-limiting step. Due to the very fast
protonation and deprotonation reactions, this feature conﬁrms
that the protons are released by the deprotonation reactions
subsequent to the rate-limiting Zn21 binding step. In further
agreement with the above conclusions, the amplitude of the
absorption change of the indicator shows that one to two
protons are released per bound Zn21, subsequent to the rate-
limiting step at pH 6.8.
Since the binding of Zn21 to (35–50)NCp7 leads to
ﬂuorescent intermediates, the pH dependence of their ﬂuores-
cence intensity is compared with the pH dependence of the
ﬂuorescence intensities of the Zn21-bound peptide and apo-
peptide (Fig. 5). At low pH, the ﬂuorescence level of the
FIGURE 3 pH-dependence of Zn21 binding to (35–50)NCp7. (a) Forward
interconversion step kf, s. The solid line is the best ﬁt to the experimental
points using Eq. 8 with the kﬁ parameters in Table 1. (b) Equilibrium constant
KM:The solid line is the best ﬁt according to Eq. 6 and theKH1,KH2,K

M1; and
KM2 values in Table 1. (c) Backward interconversion step kb, n; and
experimental values,h, calculated values according to Eq. 5. The solid line is
the best ﬁt using Eq. 9 and theKMH2,KMH3,KMH4, kb1, kb2, kb3, and kb4 values
of Table 1.
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intermediates is close to that of the apopeptide, whereas at
high pH, it approaches that of the ﬁnal complex. The marked
ﬂuorescence change in the pH range from 5 to 8 indicates
that the intermediates display various protonation states
differing by their quantum yields.
DISCUSSION
Thermodynamic and kinetic parameters of Zn21
binding to (35–50)NCp7
In our previous article (30), we investigated the kinetics of
Zn21 binding and dissociation to two point-mutated peptides
of the distal CCHC motif of NCp7. The complex formation
was analyzed on the basis of a multistep reaction model in-
volving three Zn21 binding paths due to three deprotonated
states of the coordinating motif, acting as monodentate, bi-
dentate, and tridentate ligands. The rate constants for the
intermolecular binding paths of the bidentate and tridentate
states were much smaller than expected according to elec-
trostatic considerations (36). This was attributed to confor-
mational constraints required to achieve the proper metal
coordination during folding. In addition, intermediates were
found to be involved in the reaction path. Based on the re-
action scheme that was developed for Zn21 binding to the
tridentate-mutated peptides (30), one could simply expect
that, in the intact tetradentate (35–50)NCp7 peptide, the re-
action model has to be expanded by introducing one addi-
tional binding step, due to the additional coordinating residue.
Since the associated Zn21 binding rate constant for the fully
deprotonated (35–50)NCp7 peptide would have been as high
as 73 109 M1 s1 according to the model of Fuoss (36), the
corresponding reaction step would not be resolvable by the
stopped-ﬂow method under our experimental conditions. On
the contrary, we ﬁnd a resolvable kinetic reaction phase in
the millisecond time range. Therefore, as it was previously
observed with the tridentate mutated peptides, the binding
rate constant of the native (35–50)NCp7 peptide at high pH
is lower than theoretically predicted. In addition, both the
signiﬁcant amplitude of the fast, non-time-resolvable process
in the kinetic traces of the native peptide (Fig. 2 a) and the
saturation behavior of the Zn21 concentration dependence of
kobs (Fig. 2 b) at all investigated pH values indicate that a
comparatively stable intermediate is formed before the rate-
limiting interconversion step. A possible assignment of the
slow interconversion to a protonation reaction is excluded
since the rate constant of the transition is independent of the
buffer concentration, as it was shown at pH 6. Therefore, this
process is attributed to a conformational change of the ligand
subsequent to the initial binding process.
To determine the kinetic parameters in terms of single
reaction steps, the reaction scheme in Fig. 6 is considered.
Due to the four coordinating residues, there are ﬁve pro-
tonation states of the apopeptide. The fully protonated LH14
species is assumed not to coordinate Zn21 because of unfa-
vorable electrostatics. Due to the pH dependence of the ﬂuo-
rescence of the intermediates (Fig. 5), we postulate different
protonation states: LH3*Zn
21 to L*Zn with coordination
numbers (in respect to the binding of the peptide coordinat-
ing residues) that cannot be predicted a priori. However, we
can assume that LH3*Zn
21 exhibits a coordination number
of one. Finally, four states of the ﬁnal Zn21 complex,
FIGURE 5 pH-dependence of the ﬂuorescence intensities of the different
(35–50)NCp7 forms. Apopeptide, d; intermediate Zn21-complex, s; and
ﬁnal Zn21-complex, n. The ﬂuorescence intensities of the intermediates are
obtained from the non-time-resolved amplitudes in the kinetic traces (Fig. 2).
The dotted line is the best ﬁt using Eq. 7 and the KMH2 and K

MH3 values of
Table 1. The ﬂuorescence of the ﬁnal Zn21-complex, corresponding to Atot
in the kinetic traces, and its ﬁt (solid line) are from our previous work (9).
FIGURE 4 Proton release coupled to the rate-limiting reaction step.
150 mM (35–50)NCp7 was mixed with 100 mM Zn(ClO4)2 in 5 mM MES/
NaOH pH 6.8 at 20C and a total ionic strength of 0.15 M. Time-resolved
absorption of the pH indicator Bromothymol Blue (15 mM), observed at (a)
450 nm (acidic state) and (b) 615 nm (basic state). The theoretical curves
(solid and dashed lines) correspond to a monoexponential function with
kobs ¼ 235 s1. The concentrations refer to conditions after mixing.
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differing in coordination number, are considered: LH3Zn
21
to LZn.
As for the mutated peptides (30), several reaction schemes
of increased complexity have been considered to ﬁt our data.
All reaction schemes including only a reduced number of
ﬁnal or intermediate complexes (i.e., less than four LHnZn
(n1)
or LHn*Zn
(n1) states) failed to properly ﬁt the data on the
kinetics of Zn21 binding and dissociation of the native
(35–50)NCp7 peptide, and were thus excluded. Therefore,
the data have been analyzed on the basis of the whole reac-
tion scheme, using the previously determined protonation
constants of the apopeptide (KHi) and holopeptide (KMHi) as
well as the binding constants (KMi) associated with the
overall formation of each ﬁnal Zn21 complex (9).
Since our data indicate that the reactions leading to the
intermediate complexes (left side of Fig. 6) are much faster
than the subsequent rate limiting reactions leading to the ﬁnal
complexes (right side of Fig. 6), we assume that the reactions
on the left have reached an equilibrium before the intercon-
version reactions on the right take place. As a consequence,
the pH dependence of the stability constant of the interme-
diates, KM; can be described by using only the reactions
within the dotted contour while the interconversion rate con-
stants kf and kb can be analyzed through the reaction scheme
within the solid contour.
Thermodynamic parameters from the pH dependence
of the stability constant and the ﬂuorescence intensity
of the intermediates
Since the deprotonation of two groups appears to account for
the pH dependence of KM; the data in Fig. 3 b are ﬁtted by
Eq. 6 based on a model including only twometal binding steps:
K

M ¼
K

M21K

M1K

MH2½H1 
11KH2½H1 1KH2KH1½H1 2
: (6)
Due to the steep pH dependence of KM below pH 8, only the
two more acidic protonation constants, KH1 and KH2 of the
apopeptide, likely contribute to this pH dependence. There-
fore, the binding steps involved in the pH dependence
of KM are attributed to M1* and M2* (Fig. 6). Values of
(1.36 0.6)3 103 M1 and (2.06 0.5)3 105 M1 are found
for KM1 and K

M2; respectively (Table 1). K

M1 is very similar
to KM1 associated with the overall binding step M1
determined in Bombarda et al. (9), indicating that the inter-
conversion equilibrium constant KI1 ¼ kf1/kb1 ¼ KM1/KM1 is
;1 and thus, the step I1 does not stabilize the ﬁnal complex
LH3Zn
21. This result is consistent with the hypothesis that
only one coordination is involved both in LH3*Zn
21 and
LH3Zn
21, a constraint that is probably not sufﬁcient to
reorganize and stabilize the peptide. In contrast, KM2 is ap-
proximately two orders-of-magnitude smaller than KM2 as-
sociated to the overall binding step M2, implying that KI2 ¼
kf2/kb2 ¼ KM2/KM2 ¼ 150 and thus, the step I2 substantially
stabilizes the ﬁnal LH2Zn
1 complex. Moreover, from Fig. 6
the equilibrium constant, KMH2 relating the LH2*Zn
1 and
LH3*Zn
21species, can be calculated by KMH2 ¼ KH23
KM1=K

M2: A value of 5 3 10
5 M1 is obtained, indicating
that as for the ﬁnal complexes (9), the repulsive electrostatic
interactions between the bound cation and the protons de-
crease the protonation constant in respect to that of the free
peptide (KH2 ¼ 108 M1).
Additional equilibrium constants can be extracted from the
pH dependence of the ﬂuorescence intensity of the interme-
diates (Fig. 5). This pH dependence is attributed to various
protonation states of the intermediates (Fig. 6) differing by
their quantum yields. Since the quantum yields are strongly
related to peptide folding (31), the least protonated interme-
diates LH*Zn and L*Zn with probably the highest coordi-
nation number are assumed to be the most folded and thus,
the most ﬂuorescent intermediates. In contrast, the LH3*Zn
21
complex with coordination number 1 is likely almost unfolded
and thus exhibits the same ﬂuorescence as the apopeptide.
Two protonation steps are needed to describe the pH de-
pendence of the ﬂuorescence intensity of the intermediates.
These steps are interpreted as the ones characterized by the
equilibrium constants, KMH2 and K

MH3: The following equa-
tion is used,
I ¼ ILH3Zn1 ILH2ZnK

MH2½H1 1 ILHZnKMH2KMH3½H1 2
11KMH2½H1 1KMH2KMH3½H1 2
; (7)
FIGURE 6 Reaction scheme for Zn21 binding to (35–50)NCp7. KHi,
KMHi; and KMHi correspond to the equilibrium protonation constants of the
apopeptide, the intermediate, and the ﬁnal complexes, respectively. KMHi are
the stability constants for the intermediate complexes while kﬁ and kbi are the
forward and backward rate constants, respectively, of the ith interconversion
step. The equilibrium constants of the interconversion steps are deﬁned as
KIi ¼ kﬁ/kbi. The overall Zn21 binding constants for each ﬁnal complex,
KMi, are from our previous work (9) and correspond to KMi¼ KMi 3 KIi. The
reactions within the dotted contour are used to derive Eq. 6, while the reactions
within the continuous contour are used to derive Eqs. 8 and 9.
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where ILH*Zn, ILH2*Zn, and ILH3*Zn are the ﬂuorescence
intensities of LH*Zn, LH2*Zn
1, and LH3*Zn
21, respec-
tively. Values of (6 6 3) 3 105 M1 and (1.0 6 0.5) 3 107
M1 are obtained for KMH2 and K

MH3; respectively. The
KMH2 value is in good agreement with the value inferred
from the pH dependence of KM; corroborating our attribution
of the protonation steps. The ILH*Zn value is assumed to
correspond to the ﬂuorescence plateau at high pH (Fig. 5).
Since this intensity is only 10% lower than that of the ﬁnal
holopeptide, the ﬂuorescence and thus, the folding of L*Zn
and LH*Zn are expected to be similar, explaining why the
transition between these two intermediates cannot be mon-
itored in Fig. 5.
With the knowledge of KM3; we determine K

M3 ¼ KM2 3
KH3/K

MH3 ¼ 1.2 3 107 M1 on the basis of Fig. 6. KM3 is
two and four orders of magnitude higher than KM2 and K

M1;
respectively, suggesting that the coordination number incre-
mentally increases in the corresponding intermediates. Since
Zn21 is assumed to be singly coordinated in LH3*Zn
21, the
coordination numbers of LH2*Zn
1 and LH*Zn are likely 2
and 3, respectively. Moreover, from KM3 and the previously
(9) determined KM3 (9 3 10
11 M1), it can be further
concluded that KI3 ¼ KM3/KM3 ¼ 73 104, indicating that the
step I3 signiﬁcantly stabilizes the complex.
Thermodynamic and kinetic parameters from the pH
dependence of the interconversion rate constants
As explained above, the equations to describe the pH depen-
dence of the forward and backward interconversion con-
stants, kf and kb, respectively, can be derived from the right
part of Fig. 6:
By ﬁxing KMH2 and K

MH3 to the values determined above,
the ﬁt of the kf data (Fig. 3 a) with Eq. 8 provides kf1¼ 8506
50 s1, kf2¼ 5006 50 s1, kf3¼ 4506 50 s1, and KMH4 ¼
(8.0 6 0.3) 3 108 M1. Due to its large value, KMH4 is
probably associated with the deprotonation of Cys49, which
is thought to be the last coordinating residue in the stepwise
coordination of Zn21 (9). By ﬁxing KMH4 ¼ 8.0 3 108 M1
in Eq. 8, it is possible to extrapolate kf4 ¼ 300 6 200 s1,
which represents the value of kf at high pH. The equilibrium
constant KMH4 is lower than KH4 (3 3 10
9 M1) in the
apopeptide as expected from the additional acidity provided
by the coordinated Zn21; however, the difference is small. A
consequence of the similarity of the KMH4 and KH4 values is
that KM4 ¼ KM3 3 KH4/KMH4 ¼ 4.5 3 107 M1. The close
values of KM4 and K

M3 indicate that Zn
21 is bound with
similar afﬁnity and thus, probably with the same coordina-
tion number 3 in LH*Zn and L*Zn, in line with their
similar associated ﬂuorescence. These considerations sup-
port the hypothesis that at high pH, even if deprotonated,
Cys49 does not bind Zn21 in L*Zn and thus a water
molecule remains in the coordination sphere of Zn21 in this
complex. Moreover, from KM4 and the previously deter-
mined KM4 value (2.7 3 10
16 M1), it can be further
concluded that KI4¼ KM4/KM4 ¼ 63 108, indicating that the
step I4 considerably stabilizes the ﬁnal complex. Since Zn21
is coordinated exclusively by all four residues in the last
complex (6,37), this interconversion step, besides account-
ing for the structural rearrangement necessary to bring Cys49
into the required position for subsequent binding (as in the
step I3), implies also the binding of the deprotonated Cys49
and the substitution of the remaining Zn21 bound water.
Finally, from the KIi and kﬁ values, the backward rate
constants kbi can be calculated by kbi ¼ kﬁ/KIi. Values of
1000 s1, 3 s1, 6 3 103 s1, and 5 3 107 s1 are
obtained for kb1, kb2, kb3 and kb4, respectively.
In a next step, the pH dependence of kb in Fig. 3 c was
ﬁtted to Eq. 9, by ﬁxing the protonation constants of the ﬁnal
Zn21-bound complexes, KMH2 to KMH4, to the values
determined previously (9). Due to the low KMH2 value, kb1
does not contribute to kb in the investigated pH range and
cannot be determined. Moreover, the ﬁts and various sim-
ulations show that only an upper limit can be obtained for kb4
TABLE 1 Equilibrium and kinetic parameters of Zn21 binding to (35–50)NCp7 at 20C
Step i KHi (M
1)y KMi (M
1)y KMiðM1Þ KMiðM1Þ kﬁ (s1) kbi (s1) KIi KMHi (M1)y
1 3 3 106 1 3 103 (1.3 6 0.6) 3 103 — 850 6 50 1000 0.8 —
2 1 3 108 3 3 107 (2.0 6 0.5) 3 105 (6 6 3) 3 105 500 6 50 3 6 1 1.5 3 102 3 3 103
3 6 3 108 9 3 1011 1.2 3 107 (1.0 6 0.5) 3 107 450 6 50 (9 6 3) 3 103 7 3 104 2 3 104
4 3 3 109 2.7 3 1016 4.5 3 107 (8.0 6 0.3) 3 108 300 6 200 107 6 3 108 1.0 3 105
The parameters are deﬁned in Fig. 6 and determined as described in the text.
yValues from our previous work (9).
kf ¼ kf1K

MH2K

MH3K

MH4310
3pH1 kf2K

MH3K

MH4310
2pH1 kf3K

MH4310
pH1 kf4
11KMH4310
pH1KMH3K

MH4310
2pH1KMH2K

MH3K

MH4310
3pH ; (8)
kb ¼ kb1KMH2KMH3KMH4310
3pH1 kb2KMH3KMH4310
2pH1 kb3KMH4310
pH1 kb4
11KMH4310
pH1KMH3KMH4310
2pH1KMH2KMH3KMH4310
3pH : (9)
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(#107 s1). In contrast, both kb2 (36 1 s
1) and kb3 (96 33
103 s1) are recovered more conﬁdently and are in agree-
ment with the values inferred from KIi and kﬁ. Furthermore,
the comparison of the upper limit of kb4 with the value
calculated from KI4 and kf4 suggests that a reasonable esti-
mate of kb4 is 10
7 s1.
All the kinetic and equilibrium constants are reported in
Table 1. Since all the parameters in Fig. 6 are linked together,
we have checked whether the reported values are consistent
with the complete reaction scheme in Fig. 6. For instance, we
have notably checked whether a given equilibrium constant
assumes the same value when it is calculated using alter-
native expressions involving different parameters. Despite
the complexity of the model, no deviation larger than a factor of
6 is observed on each individual value, demonstrating the full
consistency between the thermodynamic and kinetic parame-
ters. Due to the large number of parameters and the overde-
termination of the system, this stringent criterion gives a high
conﬁdence to our model.
Proposed molecular mechanism of Zn21 induced folding
of (35–50)NCp7
Coordination of a solvated metal ion by a ligand proceeds
generally via the fast formation of an outer-sphere complex
between the solvated cation and the ligand; then the substi-
tution of the ﬁrst water molecule by one coordinating atom of
the ligand leads to inner-sphere coordination. The substitu-
tion of the ﬁrst solvate water molecule is rate-limiting only if
the binding of further ligand atoms is signiﬁcantly faster. This
feature requires substantial ligand ﬂexibility because the
rearrangement of the ligand conformation, necessary to bring
the next coordinating atoms into the required position, must
be faster than the subsequent substitution of the remaining
solvate water molecules. This is obviously not the case for the
binding of Zn21 to (35–50)NCp7, since one of the most
striking aspects of our data is the evidence of intermediate
complexes and their slow conversion to the ﬁnal complexes.
With the exception of L*Zn, the intermediates do not seem
to change their coordination number during the interconver-
sion step, which thus corresponds to a conformational re-
arrangement. The precise nature of this rearrangement is
difﬁcult to assess. Nevertheless, since both LH*Zn and
L*Zn intermediates are inferred to be largely folded, their
rearrangement consists likely of minor structural changes that
provide strong stabilization, as shown by both KI3 and KI4
(Table 1). Due to the highly constrained structure adopted by
the peptide when all four coordinating residues are bound to
Zn21 (6,7,37), the coordination degree of 3 inferred for
L*Zn suggests that the peptide ﬂexibility is not sufﬁcient to
bring rapidly the fourth coordinating residue (Cys49) into the
required position to bind the metal. The structure of L*Zn as
well as that of the other intermediates is likely not optimized
and needs to be rearranged to yield a form more suitably
folded to rapidly lead to the native form. In this respect, the
interconversion step may be viewed as a rearrangement of the
peptide backbone around Zn21 to optimize the binding geom-
etry. Consequently, the decrease of kf with the coordination
degree of the intermediates is probably due to increasing con-
straints within the peptide that slow down the structural re-
arrangement.
In the previously studied point-mutated peptides, due to the
absence of one coordinating residue, the constraints within
the peptide are reduced and the optimized constrained native
folded state cannot be reached (30,38). Consequently, the
rearrangement step can proceed more rapidly than in the
tetradentate native peptide. Additionally, the lack of one
coordinating group likely lowers the stability of the interme-
diates in the tridentate-mutated peptides. Due to this lower
stability, the saturation behavior of kobs in the point-mutated
FIGURE 7 Proposed mechanism of Zn21 coordination
and induced folding of (35–50)NCp7 in the neutral pH
range. Only the species that are most relevant for Zn21
binding and dissociation are shown. The rate-limiting inter-
conversion step between LH2*Zn
1 and LH2Zn is assumed
to correspond to a rearrangement of the peptide backbone
enabling the formation of an adequately folded form that
rapidly leads to the ﬁnal LZn complex.
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peptides would be observable only at comparatively high
Zn21 concentrations, where the kobs values are too fast to be
determined. These features imply that the intermediates can-
not accumulate in the point-mutated peptides, explainingwhy
they have not been observed.
From our data, a molecular model (Fig. 7) could be
proposed to describe the major pathway for the Zn21-driven
folding of (35–50)NCp7. The ﬁnal Zn21 complex cannot
markedly form via LH2, L3, and L*Zn since these species
are not much populated at neutral pH, due to the high KH3,
KH4, and K

MH4 values. Moreover, due to the low K

M1ð1:33
103M1Þ and KI1 (0.8) values associated with the binding of
Zn21 to LH3 where only His
44 is thought to be deprotonated,
this species cannot play an important role at Zn21 concentra-
tions in the micromolar range or lower. Thus, the complex
formation will mainly start with the bidentate LH2 species
where both His44 and Cys36 residues are deprotonated. Bind-
ing of both residues to Zn21 gives the LH2*Zn
1 intermediate.
Since the slopes of the pH dependence of KM; kf, and kb
(Fig. 3) show that two deprotonation reactions occur prior
and subsequent to the rate-limiting conformational changes,
the LH2*Zn
1 intermediate is likely converted into the
appropriately folded LH2Zn
1 species. Then, the ﬁnal LZn
complex is rapidly generated through deprotonation of Cys39
and Cys49 residues. This rapid conversion into LZn nec-
essarily implies that the Cys39 and Cys49 residues are close to
Zn21 in LH2Zn
1, so that they can readily substitute the
remaining solvate molecules. In the other direction, the release
ofZn21 from the ﬁnal complexLZn does not occur efﬁciently
via L*Zn or LH*Zn, since kb4 and kb3 are by orders of
magnitude lower than kb2. Therefore, we propose that disso-
ciation starts by protonation of the ﬁnal complex to provide
LH2Zn
1, and then proceeds via LH2*Zn
1 to the apopeptide.
This study constitutes the ﬁrst quantitative molecular
model of the Zn21-triggered folding mechanism of a CCHC
zinc ﬁnger. With the exception of initial studies on CCHH
zinc ﬁngers (39), no detailed report on the kinetics of metal
binding to a zinc ﬁnger peptide has been published so far. In
the future, efforts should be made to further characterize the
intermediates, which are critical to generate the folded zinc
ﬁngers. Since the activity of HIV-1 NCp7 strongly relies on
its folded ﬁngers, the intermediates are potential targets to
inhibit NCp7.
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